Can ACE inhibitors prevent chronic allograft failure?
Division of Nephrology, Department of Medicine, UCLA School of Medicine, Los Angeles, CA 90024-1689, USA.
G M
GM
Danovitch
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000494:pharmacology / Q000627:therapeutic use*; D000818:Animals; D015815:Cell Adhesion Molecules / Q000378:metabolism; D002908:Chronic Disease; D004195:Disease Models, Animal; D006084:Graft Rejection / Q000517:prevention & control*; D006133:Growth Substances / Q000378:metabolism; D006801:Humans; D016030:Kidney Transplantation / Q000276:immunology*; D012333:RNA, Messenger / Q000187:drug effects; D051381:Rats; D018125:Receptors, Transforming Growth Factor beta / Q000187:drug effects; D016212:Transforming Growth Factor beta / Q000187:drug effects; D014184:Transplantation, Homologous / Q000276:immunology
D000806:Angiotensin-Converting Enzyme Inhibitors; D015815:Cell Adhesion Molecules; D006133:Growth Substances; D012333:RNA, Messenger; D018125:Receptors, Transforming Growth Factor beta; D016212:Transforming Growth Factor beta